3 drug(s) with this reaction
829 total reports
Syncope has been reported as an adverse reaction across 3 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 829 adverse event reports mention syncope in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with syncope, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have syncope listed in their FDA adverse event reports, sorted by report count:
In addition to syncope, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
3 drug(s) manufactured by Amgen Inc have syncope listed in their FDA adverse event reports: PEGFILGRASTIM, FILGRASTIM, IVABRADINE.
There are a combined 829 reports of syncope across 3 Amgen Inc drug(s) in the FDA adverse event database.